Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2023

Nuha A ElSayed et al. Diabetes Care. .

Abstract

The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

PubMed Disclaimer

Similar articles

  • 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2024.
    American Diabetes Association Professional Practice Committee. American Diabetes Association Professional Practice Committee. Diabetes Care. 2024 Jan 1;47(Suppl 1):S231-S243. doi: 10.2337/dc24-S012. Diabetes Care. 2024. PMID: 38078577 Review.
  • 12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical Care in Diabetes-2022.
    American Diabetes Association Professional Practice Committee. American Diabetes Association Professional Practice Committee. Diabetes Care. 2022 Jan 1;45(Suppl 1):S185-S194. doi: 10.2337/dc22-S012. Diabetes Care. 2022. PMID: 34964887 Review.
  • 6. Glycemic Targets: Standards of Care in Diabetes-2023.
    ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association. ElSayed NA, et al. Diabetes Care. 2023 Jan 1;46(Suppl 1):S97-S110. doi: 10.2337/dc23-S006. Diabetes Care. 2023. PMID: 36507646 Free PMC article. Review.
  • 17. Diabetes Advocacy: Standards of Care in Diabetes-2023.
    ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Murdock L, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Woodward CC, Gabbay RA, on behalf of the American Diabetes Association. ElSayed NA, et al. Diabetes Care. 2023 Jan 1;46(Suppl 1):S279-S280. doi: 10.2337/dc23-S017. Diabetes Care. 2023. PMID: 36507643 Free PMC article. Review.
  • 7. Diabetes Technology: Standards of Care in Diabetes-2023.
    ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association. ElSayed NA, et al. Diabetes Care. 2023 Jan 1;46(Suppl 1):S111-S127. doi: 10.2337/dc23-S007. Diabetes Care. 2023. PMID: 36507635 Free PMC article. Review.

Cited by

References

    1. Solomon SD, Chew E, Duh EJ, et al. . Diabetic retinopathy: a position statement by the American Diabetes Association. Diabetes Care 2017;40:412–418 - PMC - PubMed
    1. Diabetes Control and Complications Trial Research Group; Nathan DM, Genuth S, Lachin J, et al. . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986 - PubMed
    1. Stratton IM, Kohner EM, Aldington SJ, et al. . UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 2001;44:156–163 - PubMed
    1. Estacio RO, McFarling E, Biggerstaff S, Jeffers BW, Johnson D, Schrier RW. Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. Am J Kidney Dis 1998;31:947–953 - PubMed
    1. Yau JWY, Rogers SL, Kawasaki R, et al. .; Meta-Analysis for Eye Disease (META-EYE) Study Group . Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556–564 - PMC - PubMed